Canadians Refine The Art Of International Science

Even as Congress once again wrestles with levels of funding for the superconducting supercollider (SSC), plans for another large North American high-energy physics project are moving quietly but steadily ahead. While SSC supporters scramble to entice reluctant foreign partners to help foot an estimated $6 billion bill for what has always been promoted as a United States-led effort, the other project-a proposed $450 million Canadian accelerator-has been designed from the start with international

Written byChristopher Anderson
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

So far, the Canadian approach seems to be working better. Last month the project, known as KAON after the K mesons and other subatomic particles it will produce, was endorsed by a nuclear science panel, which advises the U.S. Department of Energy (DOE) and the National Science Foundation. The vote of confidence appears to doom the chances of a U.S. facility proposed by officials at Los Alamos National Laboratory. And in a bit of serendipity, the new science adviser to President Bush, Canadian-born physicist D. Allan Bromley, turns out to have strong ties to many of the Canadian scientists involved with the new accelerator.

The Canadians have worked hard for their success. Last month a team of officials returned from around-the-world tour of six capitals to solidify support for the KAON facility. The team's international collaboration strategy is modeled after West Germany's success in attracting international funding for its $750 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies